BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260728T015318
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:22101-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260728T015318
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:26544-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260728T015318
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:28159-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260728T015318
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:31242-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260728T015318
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:32702-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR